Soft Agar Colony Formation Assay
Materials Required
Principle
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation[1][2][3][4]. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures[3][5][6][7][8][9][10].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Reported agar concentrations vary by format: examples include a bottom/base layer around 0.5-0.6% agar/agarose and a cell-containing top layer around 0.3-0.4% agar/agarose; therefore, the selected concentration should be matched to the cited format and cell type rather than generalized across all models[3][5][9][10].
• Crystal violet has been used to stain colonies for visualization and manual counting, CyQUANT/DNA-binding dye formats quantify cellular DNA in soft agar cultures, MTT/tetrazolium formats provide metabolic colorimetric readouts, and qPCR can detect proliferation-related or cancer-stem-cell marker transcripts from soft agar cultures when molecular characterization is the endpoint[3][6][7][8][9].
• Use sterile tissue-culture plates or dishes, a 37 °C/5% CO2 incubator, water bath or heating block for agar handling, microscope or imaging system for colony inspection, colony-counting or image-analysis software when automated quantification is used, microplate reader for fluorescence or absorbance assays, and qPCR equipment when PCR-based readout is used[3][5][6][7][8][9][10].
Experimental Procedure
• Prepare molten agar or agarose and equilibrate it with warm complete medium before plating, because the method requires a solidified base layer to prevent attachment and a softer upper layer containing suspended cells; reported formats commonly pour or dispense the base layer first, allow it to solidify, then overlay the cell-containing agar layer[3][5][9][10].
• Add the base agar layer to the plate and allow it to solidify; examples include 96-well assays using 50 µL of 0.6% agar in complete DMEM chilled to solidify, and other protocol formats using approximately 0.5-0.6% base agar/agarose in complete medium[3][9][10].
• Mix the single-cell suspension with molten agar/agarose-containing complete medium to form the cell-containing top layer; reported examples include 75 µL of 0.4% cell agar in 96-well plates, 0.3% agarose cell layers in breast-cancer inhibitor assays, and approximately 0.35% soft agarose cell layers in published colony-formation examples[5][9][10].
• After the cell-containing agar layer solidifies, add complete medium above the agar and incubate at 37 °C with 5% CO2; reported incubation periods include 6-8 days for some 96-well quantitative kits and short-term formats, 14-21 days for many cancer-cell colony-counting assays, 20 days for conventional detection of HeLa contamination in hMSCs, and 30 days for digital ultrasensitive detection[3][5][6][7][9][10].
• For treatment studies, add vehicle and treatment conditions consistently to the overlay medium or agar-containing layer as described in the selected study design; Horibata and colleagues used the assay to test the PADI inhibitor BB-Cl-amidine against breast cancer cell tumorigenicity, and high-throughput studies used soft agar formats to compare compound effects in three-dimensional anchorage-independent growth assays[5][7].
• For manual readout, stain colonies when the incubation endpoint is reached, image wells or dishes, and count colonies; colony number and colony size are interpreted as measures of anchorage-independent proliferative capacity, and reduced colony formation after a genetic or drug perturbation is interpreted as reduced anchorage-independent growth under the tested condition[3][5][10].
• For quantitative readouts, measure fluorescence for DNA-binding dye assays, absorbance for tetrazolium/MTT assays, or qPCR marker expression after extracting material from soft agar; Nakamura reported Ki-67 and cyclin B mRNA detection of 0.01% HeLa cells after 5 days, CDK1 detection after 2 weeks, and ALDH1/CD133 marker detection at later time points, while noting that CDK2, PCNA, MCM7, and CD44 were not useful markers in that model[6][8][9].
• Include negative controls without cells or with non-tumorigenic cells, positive controls with a known colony-forming transformed/tumorigenic cell line, and vehicle controls for compound studies; Nakamura used MRC-5 as a non-tumorigenic negative control and HeLa as a tumorigenic positive control, while Kusakawa used HeLa-spiked hMSC mixtures to evaluate detection sensitivity[6][8][9].
• Use biological replicates and statistical comparison when reported by the study design; Nakamura reported triplicate samples and used LLOD criteria based on the mean expression of MRC-5 controls plus 3.3 standard deviations, while image-based and high-throughput formats quantify colony counts or signal intensity across wells for comparative analysis[6][7][8][9].
Troubleshooting
Problem: Colonies are difficult to distinguish from non-proliferative cell clumps.
• Possible Cause: Normal cells or high-density cultures may aggregate in soft agar without true anchorage-independent proliferation.• Literature-supported Solution: Use appropriate positive and negative control cell lines, image-based or molecular confirmation where needed, and interpret colonies cautiously because Nakamura observed MRC-5 aggregates that were not distinguishable from HeLa colonies by morphology alone at 1 week[8].
Problem: Manual counting is subjective or low-throughput.
• Possible Cause: Colony size varies and dense three-dimensional growth makes visual scoring difficult.• Literature-supported Solution: Use quantitative fluorescence, absorbance, automated imaging, digital analysis, or high-throughput plate formats when the research question requires scalable or less subjective quantification[6][7][9].
Problem: The assay is too slow for early screening.
• Possible Cause: Conventional visual or DNA-staining soft agar assays may require about 20-30 days depending on endpoint and sensitivity requirements.• Literature-supported Solution: Use validated short-format quantitative approaches only when matched to the endpoint, such as 6-8 day 96-well detection formats or qPCR detection of selected proliferation transcripts after 5 days in the specific HeLa/MRC-5 model[8][9].
References:
- [1]. Freedman VH, et al. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974;3(4):355-359. [Content Brief]
- [2]. Hamburger AW, et al. Primary bioassay of human tumor stem cells. Science. 1977;197(4302):461-463. [Content Brief]
- [3]. Borowicz S, et al. The soft agar colony formation assay. J Vis Exp. 2014;(92):e51998. [Content Brief]
- [4]. Shin SI, et al. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci U S A. 1975;72(11):4435-4439. [Content Brief]
- [5]. Horibata S, et al. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J Vis Exp. 2015;(99):e52727. [Content Brief]
- [6]. Kusakawa S, et al. Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation. Sci Rep. 2015;5:17892. [Content Brief]
- [7]. Anderson SN, et al. A high-throughput soft agar assay for identification of anticancer compound. J Biomol Screen. 2007;12(7):938-945. [Content Brief]
- [8]. Nakamura D. The evaluation of tumorigenicity and characterization of colonies in a soft agar colony formation assay using polymerase chain reaction. Sci Rep. 2023;13:5405. [Content Brief]
- [9]. Alley MC, et al. Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium salt. Life Sci. 1982;31(26):3071-3078. [Content Brief]
- [10]. Stévenin V, et al. Soft agar colony formation assay to quantify mouse embryonic fibroblast transformation after Salmonella infection. STAR Protoc. 2023;4(3):102379. [Content Brief]